MEDICINE AND PHARMACOLOGY: OBSTETRICS & GYNECOLOGY
Peer Reviewed Publications
1. Little BB, Rigsby Col. CH, Little LR. Tactical pilot and astronaut fertility: possible G force effects
on the secondary sex ratio. Aviation, Space and Environmental Medicine. 1987; 58:707-709.
2. Gilstrap LC, Little BB, Klein VR. Antibiotic use during pregnancy. Advances in Infectious
Disease. 1987;1:1-9.
3. Little BB, Duke PJ. Effects of gravitational forces on reproduction and development.
Comprehensive Therapy. 1988; 14:3-5
4. Little BB, Gilstrap LC. Cardiovascular drugs during pregnancy. Clinical Obstetrics and
Gynecology. 1989;32:13-20.
5. Little BB, Bawdon RE, Christmas JT, et al. Pharmacokinetics of zidovudine (AZT) during late
pregnancy in Long Evans rats. American Journal of Obstetrics and Gynecology. 1989;161:732734.
6. Bawdon RE, Fiskin AM, Little BB, et al. Fibronectin and postpartum infection in rabbits: an
animal model. Gynecologic and Obstetric Investigation. 1989; 28:191-194.
7. Bawdon RE, Davis LL, Little BB. Rabbit plasma fibronectin levels associated with
Staphylococcus aureus enterotoxin B: an acute phase reaction. Gynecologic and Obstetric
Investigation. 1989; 28:185-190.
8. Friedman JM, Little BB, Brent RL, et al. Potential human teratogenicity of frequently prescribed
drugs. Obstetrics and Gynecology. 1990;75:594-599.
9. Leveno KL, Little BB, Cunningham FG. National impact of tocolytic therapy on low birth weight.
Obstetrics and Gynecology. 1990;76:12-15.
10. Christmas JT, Little BB, Johnston WL, et al. Nomograms for rapid estimation of intravascular
intrauterine transfusion volume. Obstetrics and Gynecology. 1990; 75:887-891.
11. Little BB, Snell LM, Gilstrap LC, et al. Failure to recognize fetal alcohol syndrome in newborn
infants. American Journal of Diseases in Children. 1990;144:1142-1146.
12. Harstad TH, Little BB, Bawdon RE, et al. Embryocidal and teratogenic effects of pentamidine
isethionate administered to pregnant Sprague-Dawley rats. American Journal of Obstetrics and
Gynecology. 1990;163:912-916.
13. Little BB, Harstad TH, Bawdon RE, et al. Pharmacokinetics of pentamidine in late pregnant
Sprague-Dawley rats. American Journal of Obstetrics and Gynecology. 1991;164:927-930.
14. Twickler DM, Little BB, Satin AJ, et al. Renal pelvicalyceal dilation in antepartum pyelonephritis:
ultrasound findings. American Journal of Obstetrics and Gynecology. 1991; 165:1116-1119.
15. Snell LM, Little BB, Knoll KA, et al. Reliability of birth certificate reporting of congenital
anomalies. American Journal of Perinatology. 1992; 9:219-222.
16. Bohman V, Stettler RW, Little BB, et al. Seroprevalence and risk factors for hepatitis C virus
antibody in pregnant women. Obstetrics and Gynecology. 1992; 80:609-613.
17. Ramus RM, Ramin SM, Little BB, et al. Early repair of episiotomy dehiscence associated with
infection. American Journal of Obstetrics and Gynecology. 1992; 167:1104-1107.
18. Ramin SM, Little BB, Gilstrap LC. Survey of operative vaginal delivery in North America in 1990.
American Journal of Obstetrics and Gynecology. 1993; 81:307-311.
19. Hernandez C, Little BB, Dax J, et al. Meconium aspiration syndrome (MAS): prediction of need
for neonatal ventilation (NV). American Journal of Obstetrics and Gynecology. 1993; 169:61-70.
20. Little BB, Santos-Ramos R, Newell JF, et al. Megadose carbamazepine during embryogenesis.
Obstetrics and Gynecology. 1993;82:705-708.
21. Harstad TH, Buschang PH, Little BB, et al. Ultrasound anthropometric reliability. Journal of
Clinical Ultrasound. 1994; 22:531-534.
22. Hemsell DL, Little BB, Faro J, et al. Comparison of three regimens recommended by the Centers
for Disease Control and Prevention for the treatment of women hospitalized with acute pelvic
inflammatory disease. Clinical Infectious Disease. 1994; 19:720-727.
23. Christmas JT, Little BB, Knoll KA, et al. Teratogenic and embryocidal effects of zidovudine in
Sprague-Dawley rats. Journal of Infectious Diseases in Obstetrics and Gynecology. 1995;2:223227.
24. Little BB, Wilson GN, Teasley TC, et al. Fetal alcohol syndrome: diagnosis, prevention,
prognosis, and management. Dallas Medical Journal. 1995;81:21-25.
25. Little BB, Ramin SM, Cambridge BS, et al. Risk of chromosomal abnormalities, with emphasis
on live-born offspring of young mothers. American Journal of Human Genetics. 1995; 57:11781185.
26. Little BB, Patterson MA. Embryofetal effects of neuroelectric therapy (NET). Electro- and
Magnetobiology. 1996; 15:1-8.
27. Kemp PM, Little BB, Bost RO, et al. Whole blood levels of dodecanoic acid, a routinely
detectable forensic marker for a genetic disease often misdiagnosed as sudden infant death
syndrome (SIDS) – MCAD definciency. American Journal of Forensic Medicine & Pathology.
March 1996; 17(1):79-82.
28. Little BB. Immunosuppressant therapy during gestation. Seminars in Perinatology. 1997;21:143148.
29. Yonkers KA, Little BB, March D. Lithium use during pregnancy: a controversy. CNS Drugs.
1998;9:261-269.
30. Dobson A, Little BB, Scott LL. Prevention of herpes simplex virus infection and latency by
prophylactic treatment with acyclovir in a weanling mouse model. American Journal of Obstetrics
and Gynecology. 1998; 179:527-532.
31. Little BB . Pharmacokinetics during pregnancy: evidence-based maternal dose formulation.
Obstetrics and Gynecology . 1999;93(51001):858-868.
32. Little BB, Gonzales J, Snell LM, et al. Risk behaviors for sexually transmitted diseases among
gangs in Dallas , Texas . Journal of Gang Research. 1999; 6:33 -47.
33. Little BB, Kemp PM, Bost RO, et al. Abnormal allometric size of vital organs among sudden
infant death syndrome victims. Journal of Human Biology. 2000; 12:382-387.
Book Chapters
1. Little BB, Gilstrap LC, Cunningham FG. Medications in pregnancy: Part I. Concepts of human
teratology. In: Williams Obstetrics. Supplement 10. 18th (1989) ed. Norwalk, CT: Appleton and
Lange; 1991:15 pp.
2. Gilstrap LC, Little BB, Cunningham FG. Medications in pregnancy: Part II. Special
considerations. In: Williams Obstetrics. Supplement 11. 18th (1989) ed. Norwalk, CT : Appleton
and Lange; 1991:15 pp.
3. Gilstrap LC, Little BB. Medication during pregnancy: maternal and embryofetal considerations.
In: James DK, Steer PJ, Weiner CP, Gonik B eds. High Risk Pregnancy: Management Options.
London: W.B. Saunders; 1994:229-252.
4. Little BB. Medication during pregnancy. In: James DK, Steer PJ, Weiner CP, Gonik B eds. High
Risk Pregnancy: Management Options. London: W.B. Saunders; 1999:617-638.
5. Little BB. Medication during pregnancy. In: James DK, Steer PJ, Weiner CP, Gonik B eds. High
Risk Pregnancy: Management Options. 3rd ed. London : W.B. Saunders; 2006: Chapter 36.
Books Written
1. Gilstrap LC, Little BB. Drugs and Pregnancy. 1st edition. New York , New York : Elsevier Press;
1992: 33 chapters, 472 pages.
2. Gilstrap LC, Little BB. Drugs and Pregnancy. 2nd edition. New York, New York: Chapman and
Hall; 1998: 34 chapters, 523 pages.
3. Yonkers KA, Little BB. Treatment of Psychiatric Disorders During Pregnancy. Cambridge, MA:
Oxford University Press; 2001. 266 pages.
4. Little BB. Drugs and Pregnancy. 3rd edition. Cambridge, MA : Oxford University Press; 2006.